The project ProEmpower: Pre-Commercial Procurement of innovative ICT for patient empowerment and self-management for patients with type 2 diabetes mellitus has reached its piloting phase. Two diabetes self-management solutions will be piloted in four regions: Istanbul (Turkey), Amadora (Portugal), Campania (Italy) and Murcia (Spain).

empirica is supporting the regions in their preparation for the pilot operation phase, which is scheduled to start in July 2019 and end in January 2020. A total of 400 patients across the four pilots will test the solutions and provide feedback to the project consortium.

empirica is in charge of evaluating the impact of the ProEmpower solutions. Clinical and non-clinical parameters will be assessed throughout the pilot in a comparative evaluation. The solutions are expected to contribute to patient empowerment, an improved quality of life, and the overall better self-management of type 2 diabetes.

Find out more about the ProEmpower project: https://proempower-pcp.eu/